We are live on
!
Find out more
HS
HighVista Strategies Portfolio holdings
AUM
$362M
1-Year Est. Return
230.96%
This Fund
S&P 500
This Quarter
Est. Return
+1.03%
1 Year Est. Return
+230.96%
3 Year Est. Return
+518.4%
5 Year Est. Return
+644.94%
10 Year Est. Return
+2,223.31%
AUM
$269M
AUM Growth
-$21.2M
(-7.3%)
Cap. Flow
-$10M
Cap. Flow
% of AUM
-3.73%
Top 10 Holdings %
Top 10 Hldgs %
26.35%
Holding
168
New
26
Increased
41
Reduced
37
Closed
31
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$3.11M |
| 2 |
Guardant Health
GH
|
+$2.65M |
| 3 |
Janux Therapeutics
JANX
|
+$2.45M |
| 4 |
APLS
Apellis Pharmaceuticals
APLS
|
+$2.19M |
| 5 |
GE HealthCare
GEHC
|
+$1.85M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
CTLT
CATALENT, INC.
CTLT
|
+$4.58M |
| 2 |
Capri Holdings
CPRI
|
+$3.3M |
| 3 |
Amgen
AMGN
|
+$3.25M |
| 4 |
Maplebear
CART
|
+$3.2M |
| 5 |
GE Vernova
GEV
|
+$2.47M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 43.86% |
| 2 | Technology | 16.73% |
| 3 | Consumer Discretionary | 7.18% |
| 4 | Communication Services | 5.42% |
| 5 | Industrials | 4.96% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
151
Elevance Health
ELV
$84.7B
| – | – |
-2,500
| Closed | -$1.3M |
|
|
ETNB
152
DELISTED
89bio
ETNB
| – | – |
-66,787
| Closed | -$494K |
|
|
FISV
153
Fiserv Inc
FISV
$28B
| – | – |
-10,053
| Closed | -$1.81M |
|
154
VanEck Gold Miners ETF
GDX
$27.4B
| – | – |
-42,000
| Closed | -$1.67M |
|
155
Immatics
IMTX
$1.32B
| – | – |
-45,544
| Closed | -$520K |
|
156
Lithia Motors
LAD
$8.4B
| – | – |
-6,000
| Closed | -$1.91M |
|
157
Lennar Class A
LEN
$21.1B
| – | – |
-7,954
| Closed | -$1.44M |
|
158
Li Auto
LI
$12.4B
| – | – |
-21,900
| Closed | -$562K |
|
159
Eli Lilly
LLY
$1.09T
| – | – |
-1,500
| Closed | -$1.33M |
|
|
MRC
160
DELISTED
MRC Global
MRC
| – | – |
-149,800
| Closed | -$1.91M |
|
161
Netflix
NFLX
$311B
| – | – |
-20,000
| Closed | -$1.42M |
|
162
ServiceNow
NOW
$131B
| – | – |
-8,500
| Closed | -$1.52M |
|
163
Pinduoduo
PDD
$129B
| – | – |
-8,078
| Closed | -$1.09M |
|
164
RTX Corp
RTX
$301B
| – | – |
-15,400
| Closed | -$1.87M |
|
|
TSVT
165
DELISTED
2seventy bio
TSVT
| – | – |
-95,454
| Closed | -$451K |
|
166
Travere Therapeutics
TVTX
$5.75B
| – | – |
-147,233
| Closed | -$2.06M |
|
167
UroGen Pharma
URGN
$2.28B
| – | – |
-38,566
| Closed | -$490K |
|
|
CTLT
168
DELISTED
CATALENT, INC.
CTLT
| – | – |
-75,600
| Closed | -$4.58M |
|
Similar funds
SIAG
MS
WTFG
A6
PI
ACM
PPG
PWC
HighVista Strategies's Q4 2024 Portfolio in Review
As of Q4 2024, HighVista Strategies held 168 positions worth $269M, down 7.3% from $290M the previous quarter. Its ten largest holdings account for 26% of the portfolio.
HighVista Strategies withdrew a net $10M in Q4 2024, closing 31 positions and reducing 37 holdings. Its most notable exit was CATALENT, INC., an estimated $4.58M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 44% of assets, down from 46% a quarter earlier, followed by Technology and Consumer Discretionary.
Against the trend, HighVista Strategies opened a new position in Meta Platforms (Facebook) worth $3.1M.
- HighVista Strategies's largest Q4 2024 buy was Meta Platforms (Facebook): 5,300 shares worth $3.1M.
- HighVista Strategies added most to Janux Therapeutics in Q4 2024, an estimated $2.45M increase.
- HighVista Strategies's biggest Q4 2024 reduction was GE Vernova, cutting an estimated $2.47M.
- HighVista Strategies fully exited CATALENT, INC. in Q4 2024, selling an estimated $4.58M.
- HighVista Strategies's ten largest holdings make up 26% of its $269M portfolio in Q4 2024.
- HighVista Strategies opened 26 new positions and closed 31 in Q4 2024.
- HighVista Strategies's portfolio value fell 7.3% quarter-over-quarter to $269M.
Based on HighVista Strategies's 13F filing for Q4 2024, filed 14 Feb 2025.